Abstract
Alongside a broad social and racial justice movement in United States, the use of the race coefficient for eGFR from serum creatinine (eGFRcr) in Black individuals has raised a robust debate, especially around how it might create systematic discrimination in health care for this population ([1][1],[
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical journal of the American Society of Nephrology : CJASN
Paper Title
Journal
Date
